Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$197.69 - $227.29 $30,641 - $35,229
155 Added 258.33%
215 $49,000
Q3 2023

Nov 09, 2023

BUY
$201.05 - $221.7 $7,639 - $8,424
38 Added 172.73%
60 $12,000
Q2 2023

Aug 11, 2023

SELL
$211.93 - $241.33 $19,073 - $21,719
-90 Reduced 80.36%
22 $5,000
Q1 2023

May 11, 2023

BUY
$213.32 - $257.83 $23,891 - $28,876
112 New
112 $26,000
Q2 2022

Aug 05, 2022

SELL
$213.86 - $277.87 $16,894 - $21,951
-79 Reduced 89.77%
9 $2,000
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $113,801 - $130,602
-438 Reduced 83.27%
88 $23,000
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $1,086 - $1,256
-4 Reduced 0.75%
526 $165,000
Q2 2021

Aug 13, 2021

BUY
$251.87 - $278.14 $133,491 - $147,414
530 New
530 $146,000
Q1 2019

May 15, 2019

SELL
$123.7 - $156.3 $1.24 Million - $1.57 Million
-10,048 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $5.78 Million - $8.33 Million
-47,836 Reduced 82.64%
10,048 $1.27 Million
Q3 2018

Nov 13, 2018

SELL
$167.67 - $188.27 $19.8 Million - $22.2 Million
-118,056 Reduced 67.1%
57,884 $10.1 Million
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $5.73 Million - $6.77 Million
35,755 Added 25.51%
175,940 $31.6 Million
Q1 2018

May 11, 2018

SELL
$161.53 - $178.11 $3.33 Million - $3.67 Million
-20,624 Reduced 12.83%
140,185 $22.7 Million
Q4 2017

Feb 14, 2018

SELL
$147.99 - $163.95 $13.7 Million - $15.2 Million
-92,467 Reduced 36.51%
160,809 $25.7 Million
Q3 2017

Nov 14, 2017

SELL
$149.47 - $160.56 $182,951 - $196,525
-1,224 Reduced 0.48%
253,276 $38.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
254,500
254,500 $39.2 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.